Evidence map›Paper›PMID 11438593›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine.

R Girod, L W Role

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R GirodDepartment of Anatomy, Center for Neurobiology and Behavior, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
L W Role
Columbia University · US

Funding

PRESYNAPTIC ASPECTS OF NICOTINE ADDICTIONR01DA009366 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI ROLE, LORNA W · 1995 to 2000
$181k
NICOTINE/CANNABINOID INTERACTIONS AT CNS SYNAPSESF32DA005840 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GIROD, ROMAIN · 1997 to 1999
–
NIDA NIH HHS DA05840NIDA NIH HHS DA09366NIDA NIH HHS F32 DA005840
6 · The paper itself

Abstract

Attempts to mimic synaptic delivery of acetylcholine (ACh) with brief, repetitive pulses of high concentration ACh at synapses of medial habenula (MHN) and interpeduncular nucleus (IPN) neurons in vitro elicited temporally distinct facilitation and inhibition of glutamate secretion via nicotinic and muscarinic ACh receptor-mediated pathways, respectively. ACh-induced nicotinic facilitation was sustained for up to 2 hr, whereas muscarinic inhibition was transient. Prolonged exposure to nicotine inactivated nicotinic receptors selectively, thus decreasing the relative contribution of the facilitatory versus inhibitory influences of ACh. The net effect of ACh in modulating glutamatergic transmission at MHN-IPN synapses may be determined by pre-exposure to nicotine, because the drug appears to switch the balance between the facilitatory and inhibitory actions of ACh.

Indexed as

AcetylcholineAdaptation, PhysiologicalAnimalsCells, CulturedChick EmbryoCoculture TechniquesDose-Response Relationship, DrugGlutamic AcidHabenulaMesencephalonNeural InhibitionNeural PathwaysNeuronsNicotineNicotinic AgonistsNicotinic AntagonistsAcetylcholineGlutamic AcidNicotineNicotinic AgonistsNicotinic AntagonistsReceptors, MuscarinicReceptors, Nicotinic

Identifiers

PMID11438593
PMCPMC6762872
OpenAlexW1847254590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.